Next Article in Journal
The Concept of “Hypersexuality” in the Boundary between Physiological and Pathological Sexuality
Next Article in Special Issue
Reply to Ott, M.; Werneke, U. Comment on “Liu et al. Hemodialysis Treatment for Patients with Lithium Poisoning. Int. J. Environ. Res. Public Health 2022, 19, 10044”
Previous Article in Journal
The Influence of News Consumption Habits and Dispositional Traits on Trust in Medical Scientists
Previous Article in Special Issue
Hemodialysis Treatment for Patients with Lithium Poisoning
 
 
Reply published on 25 May 2023, see Int. J. Environ. Res. Public Health 2023, 20(11), 5951.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Comment

Comment on Liu et al. Hemodialysis Treatment for Patients with Lithium Poisoning. Int. J. Environ. Res. Public Health 2022, 19, 10044

1
Department of Public Health and Clinical Medicine–Medicine, Umeå University, 901 87 Umeå, Sweden
2
Sunderby Research Unit, Department of Clinical Sciences, Division of Psychiatry, Umeå University, 901 87 Umeå, Sweden
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2023, 20(10), 5843; https://doi.org/10.3390/ijerph20105843
Submission received: 15 March 2023 / Accepted: 12 May 2023 / Published: 17 May 2023
(This article belongs to the Special Issue The Fascinating World of Lithium)
In a recent article, Liu and colleagues presented a case-series of patients with lithium poisoning, with special emphasis on hemodialysis [1]. In their table 1, they cited our previous study [2], reporting a mortality rate of 4.3%. However, in our study, as already explicitly stated in the published paper, there were no fatalities related to lithium intoxication. As the authors correctly discuss, the best treatment of the different scenarios of lithium intoxication remains subject to debate. To exert its harmful and potentially life-threatening effects, lithium must enter the cell. In early acute intoxications, serum lithium levels (s-Li) reflect extracellular concentration. In chronic intoxications, however, s-Li most likely reflects intracellular concentration. Chronic intoxications often result from reduced renal excretion when lithium dosage has not been adapted [2]. Lithium is completely filtered by the glomeruli and not to 80%, as suggested by Liu et al. Then, 80% of the filtered lithium is reabsorbed in the tubuli [3]. Lithium reabsorption roughly follows sodium reabsorption. Saline infusions both prevent hypovolemia and minimize lithium reabsorption. The use of hemodialysis in the setting of chronic intoxication is mainly a question of the severity of symptoms and the residual renal function.
In acute or acute-on-therapeutic intoxications, the clinical decision to dialyze is far more complex. While blood concentrations of lithium are high, symptoms often have not yet developed. Once lithium has entered the intra-cellular compartment, the window of opportunity for the removal of lithium has passed. We compared a French study by Vodovar et al. [4] with our own Swedish data, using the same cut-offs [5]. Patients in Sweden experienced significantly lower rates of coma and cardiovascular failure. The proportion of patients dialyzed was significantly higher, especially in the group with lithium levels ≤5.2 (4% vs. 31%). Figure 1 illustrates the pathophysiological background of the two scenarios (adapted after [5]). To decide whether to dialyze in the setting of acute/acute-on-chronic intoxication, the treating physician needs to consider how much lithium is on its way to eventually enter the cells. Hemodialysis is a safe procedure. When available, we advocate its early use because, once lithium has entered the cells, tissue damage may be irreversible.

Author Contributions

Conceptualization, M.O. and U.W.; writing—original draft preparation, M.O. and U.W.; writing—review and editing, M.O. and U.W. All authors have read and agreed to the published version of the manuscript.

Conflicts of Interest

U.W. has received funding for educational activities on behalf of Region Norrbotten (Masterclass Psychiatry Programme 2014-2018, EAPM 2016 Luleå, Sweden): Astra Zeneca, Janssen, Eli Lilly, Novartis, Otsuka/Lundbeck, Servier, Shire, and Sunovion. U.W. has received lecture honoraria from Lundbeck and Janssen and has served/serves on scientific commitees for Janssen, receiving honoraria for these activities. U.W. is a shareholder of Novo Nordisk. M.O. declare no conflict of interest.

References

  1. Liu, Y.-H.; Tsai, K.-F.; Hsu, P.-C.; Hsieh, M.-H.; Fu, J.-F.; Wang, I.-K.; Liu, S.-H.; Weng, C.-H.; Huang, W.-H.; Hsu, C.-W.; et al. Hemodialysis Treatment for Patients with Lithium Poisoning. Int. J. Environ. Res. Public Health 2022, 19, 10044. [Google Scholar] [CrossRef] [PubMed]
  2. Ott, M.; Stegmayr, B.; Renberg, E.S.; Werneke, U. Lithium intoxication: Incidence, clinical course and renal function—A population-based retrospective cohort study. J. Psychopharmacol. 2016, 30, 1008–1019. [Google Scholar] [CrossRef] [PubMed]
  3. Thomsen, K.; Schou, M. Renal lithium excretion in man. Am J Physiol. 1968, 215, 823–827. [Google Scholar] [CrossRef] [PubMed]
  4. Vodovar, D.; El Balkhi, S.; Curis, E.; Deye, N.; Mégarbane, B. Lithium poisoning in the intensive care unit: Predictive factors of severity and indications for extracorporeal toxin removal to improve outcome. Clin. Toxicol. 2016, 54, 615–623. [Google Scholar] [CrossRef] [PubMed]
  5. Ott, M.; Stegmayr, B.; Salander Renberg, E.; Werneke, U. Prognosis and outcome of severe lithium poisoning: Authors’ reply. J. Psychopharmacol. 2017, 31, 1275–1277. [Google Scholar]
Figure 1. Scenarios of severe acute or acute-on-therapeutic intoxication with (A) and without hemodialysis (B).
Figure 1. Scenarios of severe acute or acute-on-therapeutic intoxication with (A) and without hemodialysis (B).
Ijerph 20 05843 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ott, M.; Werneke, U. Comment on Liu et al. Hemodialysis Treatment for Patients with Lithium Poisoning. Int. J. Environ. Res. Public Health 2022, 19, 10044. Int. J. Environ. Res. Public Health 2023, 20, 5843. https://doi.org/10.3390/ijerph20105843

AMA Style

Ott M, Werneke U. Comment on Liu et al. Hemodialysis Treatment for Patients with Lithium Poisoning. Int. J. Environ. Res. Public Health 2022, 19, 10044. International Journal of Environmental Research and Public Health. 2023; 20(10):5843. https://doi.org/10.3390/ijerph20105843

Chicago/Turabian Style

Ott, Michael, and Ursula Werneke. 2023. "Comment on Liu et al. Hemodialysis Treatment for Patients with Lithium Poisoning. Int. J. Environ. Res. Public Health 2022, 19, 10044" International Journal of Environmental Research and Public Health 20, no. 10: 5843. https://doi.org/10.3390/ijerph20105843

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop